New London-based hub delivers real-time market clarity through AI-powered insights and human expertise.
ZHUBEI CITY, June 1, 2026 /PRNewswire/ — Airoha Technology today announced its inaugural exhibition at …
US President Donald Trump waves as he returns to the White House in Washington, DC, …
by Asia Insider
Manila, March 25, 2025 – FunStep, a Philippine health technology company, announced today that it …
by Editor
ZHUBEI CITY, June 1, 2026 /PRNewswire/ — Airoha Technology today announced its inaugural exhibition at …
by Asia Insider
Ho Chi Minh City immigration officials urge travelers to verify visas, declarations, and stay limits …
by Asia Insider
Latest News
-
-
US President Donald Trump waves as he returns to the White House in Washington, DC, …
-
Take Your Shot & Make Your Moment: OPPO Ignites Football Culture with Technology at the UEFA Champions League Final
by Asia InsiderBUDAPEST, HUNGARY – Media OutReach Newswire – 31 May 2026 – The 2025/26 UEFA Champions …
-
Ruvi AI (RUVI) Introduces Staking in Its Latest Ecosystem Upgrade, Expanding Utility for Token Holders
by Asia InsiderDUBAI, United Arab Emirates, May 31, 2026 (GLOBE NEWSWIRE) — Markets are pricing roughly 97.5% …
-
CGTN: China-Africa ties at 70: From shared struggles to a common dream of modernization
by Asia InsiderBEIJING, May 31, 2026 (GLOBE NEWSWIRE) — This year marks the 70th anniversary of China-Africa …
-
FOSHAN, CHINA – Media OutReach Newswire – 31 May 2026 – As global travelers seek …
-
AI: Digital to Physical | BEYOND Expo 2026 Leads Transformative Global Direction of Tech
by Asia InsiderMACAO, May 31, 2026 /PRNewswire/ — The BEYOND Expo 2026 has shown what the future looks …
-
Ho Chi Minh City immigration officials urge travelers to verify visas, declarations, and stay limits …
-
Japan’s Defense Minister Shinjiro Koizumi attends the 23rd Shangri-La Dialogue summit in Singapore on May …
-
Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
by Asia InsiderFirst investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with chemotherapy in first-line non-small cell lung …